| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 66,759 | 64,837 | 58,371 | 57,996 | | Cost of Revenue | 38,224 | 36,694 | 33,563 | 34,503 | | | Gross Profit | 28,535 | 28,143 | 24,808 | 23,493 | | | Operating Expenses | | Research Development | 3,292 | 2,893 | 2,079 | 2,404 | | Selling General and Administrative | 16,780 | 16,287 | 14,829 | 12,887 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,463 | 8,963 | 7,900 | 8,202 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (29) | 22 | 174 | 358 | | Earnings Before Interest And Taxes | 8,434 | 8,985 | 8,074 | 8,560 | | Interest Expense |
-
|
-
|
-
| 17 | | Income Before Tax | 8,434 | 8,985 | 8,074 | 8,543 | | Income Tax Expense | 2,349 | 3,144 | 2,537 | 3,151 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,085 | 5,841 | 5,537 | 5,392 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,085 | 5,841 | 5,537 | 5,392 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,085 | $5,841 | $5,537 | $5,392 |
|
0.47% Nasdaq 0.00%
Income Statement
